Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing Neutropenia Incidence by Changing the Date of Eflapegrastim Administration in Breast Cancer Patients Who Have Experienced Neutropenia After Chemotherapy

NCT05949333 is registered in ClinicalTrials.gov with Eunseong Medical Foundation Good GANG-AN HOSPITAL as lead sponsor.

NCT NCT05949333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05949333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing Neutropenia Incidence by Changing the Date of Eflapegrastim Administration in Breast Cancer Patients Who Have Experienced Neutropenia After Chemotherapy
Lead sponsor
Eunseong Medical Foundation Good GANG-AN HOSPITAL
Phase
Phase 4
Overall status
Unknown status
Start date
November 7, 2023
Completion date
July 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms